A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer

Overview of attention for article published in Gynecologic Oncology, October 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 1 X user

guideline: 1 clinical guideline source

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 1 X post from an account with 2,589 followers.

Open Access UCL Research: A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer https://t.co/VfmZL2dXwZ

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.